期刊
NATURE REVIEWS DRUG DISCOVERY
卷 13, 期 11, 页码 852-869出版社
NATURE PORTFOLIO
DOI: 10.1038/nrd4422
关键词
-
资金
- US National Institutes of Health [DK097075, HL092188, DK083385, HL098294, HL114457, DK50189, HL60569, DK95491, HL119837]
- Crohn's and Colitis Foundation of America
Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes associated with disorders such as inflammatory bowel disease, pathogen infection and acute lung injury, as well as during ischaemia-reperfusion injury. HIF stabilization and hypoxia-induced changes in gene expression have a profound impact on the inflamed tissue microenvironment and on disease outcomes. Although the mechanism that initiates HIF stabilization may vary, the final molecular steps that control HIF stabilization converge on a set of oxygen-sensing prolyl hydroxylases (PHDs) that mark HIFs for proteasomat degradation. PHDs are therefore promising therapeutic targets. In this Review, we discuss the emerging potential and associated challenges of targeting the PHD-HIF pathway for the treatment of inflammatory and ischaemic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据